http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102652746-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5f3060fca5c547d0a7cf603351fe777
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
filingDate 2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f408951e12368c96de90768b4eb8ac2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21ed78d279c9e5dcbdd40c64a3bb43be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26b0d80f4f2cb3e98cf6bf97dc8080dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7888e967e38742b703cbcdeb83f56d0a
publicationDate 2012-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102652746-A
titleOfInvention Pharmaceutical composition containing clopidogrel and pharmaceutically acceptable salts thereof and preparation method of pharmaceutical composition
abstract The invention relates to a compound composition preparation, as well as a preparation method and a use thereof, and particularly relates to a pharmaceutical composition taking clopidogrel and pharmaceutically acceptable salts thereof, as well as atorvastatin calcium as active ingredients, and the preparation method of the pharmaceutical composition. The pharmaceutical composition can be used for preventing and treating cardiovascular and cerebrovascular diseases and performing anti-atherosclerotic and anti-thrombotic treatment, and can further improve the single treatment effect of the clopidogrel and realize the synergy. After the pharmaceutical composition disclosed by the invention is used for preparing a pharmaceutical preparation, the compliance of a patient can be improved.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103690955-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109180701-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105816860-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114532528-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103690955-A
priorityDate 2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466364123

Total number of triples: 23.